<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Genet</journal-id>
<journal-id journal-id-type="publisher-id">Front. Genet.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Genetics</journal-title>
</journal-title-group>
<issn pub-type="epub">1664-8021</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32670353</article-id>
<article-id pub-id-type="pmc">7327112</article-id>
<article-id pub-id-type="doi">10.3389/fgene.2020.00596</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Genetics</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Novel Microdeletion in the X Chromosome Leads to Kallmann Syndrome, Ichthyosis, Obesity, and Strabismus</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ma</surname>
<given-names>Wanlu</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mao</surname>
<given-names>Jiangfeng</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Xi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Duan</surname>
<given-names>Lian</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Song</surname>
<given-names>Yuwen</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/955287/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lian</surname>
<given-names>Xiaolan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zheng</surname>
<given-names>Junjie</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Zhaoxiang</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nie</surname>
<given-names>Min</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/677615/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wu</surname>
<given-names>Xueyan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c002">
<sup>*</sup>
</xref>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences</institution>, <addr-line>Beijing</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Endocrinology, The Second Hospital of Shandong University</institution>, <addr-line>Jinan</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department of Endocrinology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University</institution>, <addr-line>Beijing</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Enrico Baruffini, University of Parma, Italy</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Fernando de Castro, Cajal Institute (CSIC), Spain; Agnieszka Gach, Polish Mother’s Memorial Hospital Research Institute, Poland</p>
</fn>
<corresp id="c001">*Correspondence: Min Nie, <email>nm_pumch@aliyun.com</email></corresp>
<corresp id="c002">Xueyan Wu, <email>wsheyan@vip.sina.com</email></corresp>
<fn fn-type="other" id="fn004">
<p>This article was submitted to Genetic Disorders, a section of the journal Frontiers in Genetics</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>24</day>
<month>6</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<volume>11</volume>
<elocation-id>596</elocation-id>
<history>
<date date-type="received">
<day>07</day>
<month>2</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>5</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2020 Ma, Mao, Wang, Duan, Song, Lian, Zheng, Liu, Nie and Wu.</copyright-statement>
<copyright-year>2020</copyright-year>
<copyright-holder>Ma, Mao, Wang, Duan, Song, Lian, Zheng, Liu, Nie and Wu</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>A large deletion in Xp22.3 can result in contiguous gene syndromes, including X-linked ichthyosis (XLI) and Kallmann syndrome (KS), presenting with short stature, chondrodysplasia punctata, intellectual disability, and strabismus. XLI and KS are caused by the deletion of <italic>STS</italic> and <italic>ANOS1</italic>, respectively.</p>
</sec>
<sec>
<title>Method</title>
<p>Two KS patients with XLI were screened to identify possible pathogenic mutations using whole exome sequencing. The clinical characteristics, molecular genetics, treatment outcomes, and genotype–phenotype association for each patient were analyzed.</p>
</sec>
<sec>
<title>Results</title>
<p>We identified a novel 3,923 kb deletion within the Xp22.31 region (chrX: 5810838–9733877) containing <italic>STS</italic>, <italic>ANOS1</italic>, <italic>GPR143</italic>, <italic>NLGN4X</italic>, <italic>VCX-A</italic>, <italic>PUDP</italic>, and <italic>PNPLA4</italic> in patient 1, who presented with KS, XLI, obesity, hyperlipidemia, and strabismus. We identified a novel 5,807 kb deletion within the Xp22.31-p22.33 regions (chrX: 2700083–8507807) containing <italic>STS</italic>, <italic>ANOS1</italic>, and other 24 genes in patient 2, who presented with KS, XLI, obesity, and strabismus. No developmental delay, abnormal speech development, or autistic behavior were noticed in either patient.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>We identified two novel microdeletions in the X chromosome leading to KS and XLI. These findings contribute to the understanding of the molecular mechanisms that drive contiguous gene syndromes. Our research confirmed that the Kallmann-Ichthyosis phenotype is caused by microdeletions at the chromosome level.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Kallmann syndrome</kwd>
<kwd>X-linked ichthyosis</kwd>
<kwd>X chromosome microdeletion</kwd>
<kwd>obesity</kwd>
<kwd>strabismus</kwd>
</kwd-group>
<counts>
<fig-count count="5"></fig-count>
<table-count count="0"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="69"></ref-count>
<page-count count="10"></page-count>
<word-count count="0"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="S1">
<title>Introduction</title>
<p>Idiopathic hypogonadotropic hypogonadism (IHH) is a genetically heterogeneous disorder, which can be classified into normosmic idiopathic hypogonadotropic hypogonadism (nIHH) and Kallmann syndrome (KS, MIM 147950, 244200, 308700, 610628, 612370, and 612702) (<xref ref-type="bibr" rid="B41">Maya-Nuñez et al., 1999</xref>; <xref ref-type="bibr" rid="B60">Trarbach et al., 2005</xref>; <xref ref-type="bibr" rid="B31">Köhn and Schuppe, 2014</xref>; <xref ref-type="bibr" rid="B6">Boehm et al., 2015</xref>; <xref ref-type="bibr" rid="B7">Bonomi et al., 2018</xref>; <xref ref-type="bibr" rid="B58">Stamou and Georgopoulos, 2018</xref>). KS, which is caused by a gonadotrophin-releasing hormone (GnRH) deficiency and hypoplasia of the olfactory bulbs (<xref ref-type="bibr" rid="B41">Maya-Nuñez et al., 1999</xref>; <xref ref-type="bibr" rid="B60">Trarbach et al., 2005</xref>; <xref ref-type="bibr" rid="B46">Mitchell et al., 2011</xref>; <xref ref-type="bibr" rid="B31">Köhn and Schuppe, 2014</xref>; <xref ref-type="bibr" rid="B58">Stamou and Georgopoulos, 2018</xref>), is characterized by hypogonadotropic hypogonadism, anosmia or hyposmia, and non-reproductive phenotypes including mirror movement, unilateral renal agenesis, eye movement disorders, hearing loss, and cleft lip/palate. KS has a prevalence of around 1:8,000 in men and 1:40,000 in women (<xref ref-type="bibr" rid="B17">de Castro et al., 2017</xref>). Mutations in genes that disrupt the development and migration of GnRH neurons may cause KS (<xref ref-type="bibr" rid="B58">Stamou and Georgopoulos, 2018</xref>). Current known mutations in various genes are accountable for ∼40% of cases of IHH (<xref ref-type="bibr" rid="B7">Bonomi et al., 2018</xref>). While mutations in some genes primarily cause KS and some cause nIHH only, mutations in some other genes have been linked to both KS and nIHH. Gene mutations that are only present in KS probands include <italic>ANOS1</italic> (alias <italic>KAL1</italic>), <italic>SOX10</italic>, <italic>SEMA3A</italic>, <italic>FEZF1</italic>, <italic>DUSP6</italic>, <italic>RMST</italic>, and <italic>NDNF</italic> (<xref ref-type="bibr" rid="B45">Miraoui et al., 2013</xref>; <xref ref-type="bibr" rid="B44">Messina et al., 2020</xref>; <xref ref-type="bibr" rid="B57">Stamou et al., 2020</xref>). Genes that can cause both KS and nIHH include <italic>FGFR1</italic>, <italic>NSMF</italic>, <italic>PROK2</italic>, <italic>PROKR2</italic>, <italic>CHD7</italic>, <italic>FGF8</italic>, <italic>WDR11</italic>, <italic>HS6ST1</italic>, <italic>FGF17</italic>, <italic>IL17RD</italic>, <italic>SPRY4</italic>, <italic>FLRT3</italic>, <italic>SEMA7A</italic>, <italic>AXL</italic>, <italic>SEMA3E</italic>, <italic>PLXNA1</italic>, <italic>KLB</italic>, <italic>NTN1</italic>, <italic>DCC</italic>, and <italic>AMHR2</italic> (<xref ref-type="bibr" rid="B1">Abreu et al., 2008</xref>; <xref ref-type="bibr" rid="B11">Canto et al., 2009</xref>; <xref ref-type="bibr" rid="B45">Miraoui et al., 2013</xref>; <xref ref-type="bibr" rid="B56">Stamou et al., 2016</xref>; <xref ref-type="bibr" rid="B38">Marcos et al., 2017</xref>; <xref ref-type="bibr" rid="B64">Xu et al., 2017</xref>; <xref ref-type="bibr" rid="B8">Bouilly et al., 2018</xref>; <xref ref-type="bibr" rid="B35">Maione et al., 2018</xref>; <xref ref-type="bibr" rid="B37">Malone et al., 2019</xref>; <xref ref-type="bibr" rid="B67">Young et al., 2019</xref>). Mutations in TUBB3 and PTCH1 may also cause syndromic diseases including KS (<xref ref-type="bibr" rid="B46">Mitchell et al., 2011</xref>; <xref ref-type="bibr" rid="B4">Barraud et al., 2020</xref>). A brief chronology of genes linked to KS was summarized (<xref ref-type="fig" rid="F1">Figure 1</xref>). KS can be inherited in either an X-linked recessive, autosomal dominant, or autosomal recessive pattern, often associated with chromosomal abnormalities including lp21.1, 2q32.2, 8q21.13, 14q21.2, and Xp22.31 (<xref ref-type="bibr" rid="B25">Hamada et al., 2013</xref>). <italic>ANOS1</italic>, located at the Xp22.3 locus, encodes the protein anosmin-1 and was the first gene found to cause X-linked KS.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>A brief chronology of genes discovered for Kallmann syndrome (KS). Genes in red show genes that only cause KS. Genes in blue show genes that can cause both KS and normosmic idiopathic hypogonadotropic hypogonadism (nIHH). Two genes in black mean they cause syndromic diseases including KS. Genes with asterisk show they can cause not only KS or KS/nIHH but also syndromic diseases including KS.</p>
</caption>
<graphic xlink:href="fgene-11-00596-g001"></graphic>
</fig>
<p>Ichthyoses comprises a heterogeneous group of genetic disorders characterized by cornification and scaling of the skin, with either an autosomal or X-linked inheritance pattern. X-linked ichthyosis (XLI, OMIM:308100), which typically results in the early onset of dark, dry, and irregular scales affecting the limb and trunk, is caused by the deletion of the <italic>STS</italic> gene, encoding steroid sulfatase and located near <italic>ANOS1</italic> at Xp22.3 (<xref ref-type="bibr" rid="B59">Takeichi and Akiyama, 2016</xref>).</p>
<p>Chromosomal rearrangements, especially large terminal or interstitial deletions of Xp22.3, have been described in patients with various disease associations known as contiguous gene syndromes. Abnormalities in Xp22.3 can result in short stature, chondrodysplasia punctata, intellectual disability, strabismus, XLI, and KS. The Xp 22.31 region contains several genes, including <italic>STS</italic>, <italic>ANOS1</italic>, <italic>NLGN4X</italic>, <italic>HDHD1</italic> (<italic>PUDP</italic>), <italic>PNPLA4</italic>, and the <italic>VCX</italic> cluster. Submicroscopic deletions of <italic>STS</italic> and <italic>ANOS1</italic> may lead to KS and XLI (<xref ref-type="bibr" rid="B51">Nagai et al., 2017</xref>). However, the genomic bases of other microdeletions within the Xp22.31 region remain unclear. We, therefore, sought to detect and confirm the pathogenic mutations for two patients presenting with both KS and ichthyosis.</p>
</sec>
<sec id="S2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="S2.SS1">
<title>Subjects</title>
<p>Two KS patients with XLI were recruited from the Department of Endocrinology, Peking Union Medical College Hospital (PUMCH) from January 2002 to July 2019 and screened. This study was approved by the Ethics Committee of PUMCH. Signed informed consent was obtained from both patients.</p>
</sec>
<sec id="S2.SS2">
<title>Clinical Evaluation</title>
<p>In both cases, a thorough medical history was collected. A thorough physical examination was carried out, including both patients’ height, weight, skin condition, and external genital examination. Laboratory assessments included analysis of sex hormones, anterior pituitary hormones, and a triptorelin-stimulating test. Radiographic imaging assessments included an olfactory bulb and tract nerve MRI, a pituitary MRI, and a urinary ultrasound. Luteinizing hormone (LH), follicle-stimulating hormone (FSH), and testosterone levels were measured via a chemiluminescent method using a commercial kit (ACS 180 Automatic Chemiluminescence System; Bayer, Germany). Testicular size was measured using a Prader orchidometer.</p>
</sec>
<sec id="S2.SS3">
<title>Genetic Analyses</title>
<p>Genomic DNA was extracted from peripheral white blood cells using a DNA Extraction Kit (QIAamp DNA; Qiagen, Germany). Pathogenic mutations were identified using whole exome sequencing (MyGenostics, Inc., Beijing, China). Genes related to KS included (but were not limited to) ANOS1, NSMF, FGFR1, FGF8, FGF17, IL17RD, PROK2, PROKR2, HS6ST1, CHD7, WDR11, SEMA3A, TUBB3, and SOX10 (<xref ref-type="bibr" rid="B58">Stamou and Georgopoulos, 2018</xref>). Genes related to ichthyosis were also included, including (but not limited to) STS, FLG, ABCA12, ALOXE3, ALOX12B, CERS3, CYP4F22, PNPLA1, TGM1, KRT1, KRT10, and KRT2 (<xref ref-type="bibr" rid="B59">Takeichi and Akiyama, 2016</xref>). Sequencing was performed using the Illumina HiSeq2000 platform (110-bp paired-end sequencing) according to the standard protocol. The overall sequencing coverage of the target regions was ≥98.95% for a 100× depth of coverage in each chromosome. The coverage of target regions was normalized and compared with the average normalized data of all other samples of the same run to obtain the ratio of the relative coverage in order to detect deletions and duplications in the patients’ genome sequences. The regions where the ratio was below 0.7 were considered putative deletions, while the regions where the ratio rose above 1.3 were speculated to be putative duplications. Variant filtering of the data was done assuming autosomal recessive inheritance according to the pedigree of the consanguineous family. We included frameshift, nonsense, missense, and acceptor and donor splice site variants, as well as variants with minor allele frequency (MAF) of 0.1% in the Single Nucleotide Polymorphism Database (dbSNP build 137), the 1000 Genomes Project, the National Heart, Lung, and Blood Institute (NHLBI), the Exome Sequencing Project Exome Variant Server (EVS), the UCSC common SNP database, and an internal control database using SAMtools (version 1.4) and SOAPsnp software (version 2.0) for further analysis. Whole exome data were deposited and released by the National Center for Biotechnology information (NCBI) database (SRR11745079 for patient 1 and SRR11745080 for patient 2).</p>
</sec>
</sec>
<sec id="S3">
<title>Results</title>
<sec id="S3.SS1">
<title>Clinical Observations</title>
<p>Patient 1 was referred to our hospital when he was 14 years old, with complaints of absent pubertal development and anosmia. He had bilateral cryptorchidism and had undergone a bilateral orchiopexy at 14 years of age. Physical examination revealed a height of 168 cm (+0 SD), weight of 73 kg (+1.5 SD), body mass index (BMI) of 25.9 kg/m<sup>2</sup>, and waist circumference of 90 cm. His skin was dry. Acanthosis nigricans was observed in the neck and the armpits (<xref ref-type="fig" rid="F2">Figure 2A</xref>). Desquamation and gray-brown scaly skin could be seen in the abdomen and lower extremities (<xref ref-type="fig" rid="F2">Figure 2B</xref>). His breasts were staged as Tanner B3 and pubic hair as P1. His flaccid penile length was 1.5 cm (<xref ref-type="fig" rid="F2">Figure 2C</xref>). Both of his testicular volumes were 1 ml. Ophthalmic examination revealed strabismus, nystagmus, and amblyopia in both eyes. His eyes could follow movement, and convergence was normal. He had undergone surgery for right eye ptosis at 7 years of age. His father is 160 cm tall, and his mother is 155 cm tall.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Clinical features in patient 1. <bold>(A)</bold> Acanthosis nigricans can present in the neck. <bold>(B)</bold> Desquamation and gray-brown scaly scales could be seen in the lower extremities. <bold>(C)</bold> Testicular volume was 1 ml bilaterally, with pubic hair P1 and testis length of 1.5 cm.</p>
</caption>
<graphic xlink:href="fgene-11-00596-g002"></graphic>
</fig>
<p>Patient 2 is a 19-year-old boy. He was referred to our hospital at 14 years of age due to absent pubertal development and a poor sense of smell. On physical examination, he was obese with a height of 153 cm (−1.7 SD), weight of 62 kg (−0.6 SD), and BMI of 26.5 kg/m<sup>2</sup>. Acanthosis nigricans was detected in his neck. Rough and scaly skin could be seen in the neck, abdomen, and lower extremities (<xref ref-type="fig" rid="F3">Figures 3A–C</xref>). His breasts were staged as Tanner B1 and pubic hair as P1. His flaccid penile length was 3 cm. The testicles were not palpable (<xref ref-type="fig" rid="F3">Figure 3D</xref>). Ophthalmic examination indicated strabismus in the left eye and ptosis in the right eyelid. He was 168 cm tall when at 20 years old. His father is 165 cm tall, and his mother is 154 cm tall. His mother had menarche at 13 years old. Both his parents had a normal sense of smell and mental development.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Clinical features in patient 2. <bold>(A–C)</bold> Rough and fish-scaly skin could be seen in the lower extremities and in the abdomen. Patient was abdominal obese. <bold>(D)</bold> Patient had no pubertal development. The penis was 3 cm in the length. The testicle was not palpable.</p>
</caption>
<graphic xlink:href="fgene-11-00596-g003"></graphic>
</fig>
<p>Both patients showed normal mental development. Both patients and their parents denied any behavioral abnormality, abnormal speech development, or autistic behavior. Both patients denied neurological symptoms including headache, dizziness, nausea, vomiting, lack of consciousness, seizure, involuntary movement, or visual defect.</p>
</sec>
<sec id="S3.SS2">
<title>Diagnostic Laboratory Assessments</title>
<p>In patient 1, the baseline levels of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) were 1.27 IU/L (1.24–8.62) and 1.25 IU/L (1.27–19.26), respectively. LH and FSH increased to 1.83 and 3.50 IU/L, respectively, after administration of a triptorelin stimulating test (100 μg of Triptorelin was intramuscularly injected). Serum lipid profiling indicated a triglyceride (TG) level of 2.29 mmol/L (0.45–1.81), a total cholesterol (TC) level of 3.92 mmol/L (2.9–5.7), and a low-density lipoprotein cholesterol (LDL-C) level of 2.50 mmol/L (2.07–3.12). The results of additional laboratory assessments are shown in <xref ref-type="supplementary-material" rid="TS1">Supplementary Table S1</xref>.</p>
<p>In patient 2, the baseline levels of LH and FSH were 0.0 IU/L (1.5–9.3) and 0.0 IU/L (1.4–18.1), respectively. LH and FSH increased to 0.24 and 2.18 IU/L, respectively, after administration of a triptorelin-stimulating test (100 μg of Triptorelin was injected intramuscularly). Serum lipid profiling showed a TG level of 0.98 mmol/L (0.45–1.70), a TC level of 2.67 mmol/L (2.85–5.70), and a LDL-C level of 1.58 mmol/L (2.07–3.12). The results of additional laboratory assessments are shown in <xref ref-type="supplementary-material" rid="TS1">Supplementary Table S1</xref>.</p>
<p>An abdominal ultrasound revealed normal bilateral kidneys in both patients.</p>
</sec>
<sec id="S3.SS3">
<title>Radiographic Imaging Results</title>
<p>In patient 1, an ultrasound found bilateral testis located in the scrotum. An MRI revealed dysplasia of the bilateral olfactory bulb and tract (<xref ref-type="fig" rid="F4">Figure 4A</xref>). The bone age was determined to be 13.5 years old.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Brain MRI of both patients. <bold>(A)</bold> MRI revealed bilateral dysplasia of olfactory bulb, tract, and sulcu in patient 1. <bold>(B)</bold> MRI revealed bilateral dysplasia of olfactory bulb, tract, and sulcu in patient 2.</p>
</caption>
<graphic xlink:href="fgene-11-00596-g004"></graphic>
</fig>
<p>In patient 2, an MRI indicated dysplasia of the bilateral olfactory bulb and tract (<xref ref-type="fig" rid="F4">Figure 4B</xref>). His bone age was determined to be 13.5 years old.</p>
</sec>
<sec id="S3.SS4">
<title>Treatment</title>
<p>An otolaryngology consultation implied that patient 1 had complete anosmia. A dermatology consultation confirmed the diagnosis of ichthyosis. Human chorionic gonadotropin (HCG, 3,000 U) was intramuscularly injected twice per week for 2 weeks, and patient 1’s testosterone level rose from 0.50 to 0.65 ng/ml, indicating a poor response to HCG therapy. A treatment of 80 mg of oral testosterone undecanoate taken three times a day was then administered. One year after beginning oral testosterone treatment, his penis increased to 6 cm in flaccid length. To treat the ichthyosis, a silicone cream was applied externally twice a day and was effective in relieving skin dryness.</p>
<p>For patient 2, oral testosterone undecanoate was given at 40 mg twice a day for 3 months. Then, a combined therapy consisting of HCG 5,000 U and HMG 150 U was intramuscularly injected once a week. One year after beginning treatment, testicular volume had increased to 6 ml bilaterally, and pubic hair had increased to P3 according to the Tanner staging system.</p>
</sec>
<sec id="S3.SS5">
<title>Pathogenic Mutations</title>
<p>In patient 1, whole exome sequencing analysis identified a 3,923-kb deletion within the Xp22.31 region (chrX:5810838-9733877) compared to normal people (<xref ref-type="fig" rid="F5">Figures 5A,C</xref>). The deleted region contains the <italic>GPR143</italic>, <italic>NLGN4X</italic>, <italic>VCX-A</italic>, <italic>PUDP</italic>, <italic>PNPLA4</italic>, <italic>STS</italic>, and <italic>ANOS1</italic> genes. A heterozygotic missense variant in <italic>NSMF</italic> (c.410A &gt; C, p.Q137P) was also detected. This gene is located at chr9: 140342022–140353786, and mutation of this gene could cause KS inherited in an autosomal dominant mode. The variant was predicted to be likely benign with ACMG classification<sup><xref ref-type="fn" rid="footnote1">1</xref></sup>, damaging with SIFT, probably damaging with Polyphen2 and disease causing with Mutation taster. It was not found in gnomAD, and no publications were found for this variant on VarSome. This gene variant comes from the father (<xref ref-type="supplementary-material" rid="FS1">Supplementary Figure S1</xref>), who experienced a normal pubertal development. His mother did not demonstrate any pubertal development abnormalities, and both of his parents showed no chromosomal microdeletion.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Segmental deletion in the X chromosome in both patients. <bold>(A)</bold> A 3,923-kB deletion within the Xp22.31 regions (chrX: 5810838–9733877) containing GPR143, NLGN4X, VCX, PUDP, PNPLA4, STS, and ANOS1 in patient 1. <bold>(B)</bold> A 5,807-kB deletion within the Xp22.31-Xp22.33 regions (chrX: 2700083–8507807) in patient 2, including the following genes: XG, GYG2, ARSDAS1, ARSD, ARSE, ARSH, ARSF, LINC01546, MXRA5, PRKX, PRKX-AS1, LOC389906, LOC101928201, NLGN4X, LOC105373156, MIR4770, VCX3A, PUDP, MIR4767, STS, VCX, PNPLA4, MIR651, VCX2, VCX3B, and ANOS1. <bold>(C)</bold> Normal people covering the same region on X chromosome. <italic>Y</italic>-axis refers to the ratio of relative coverage of target regions of our patients to that of the average normalized data of all other samples of the same run. The regions where the ratio was below 0.7 were considered putative deletions.</p>
</caption>
<graphic xlink:href="fgene-11-00596-g005"></graphic>
</fig>
<p>In patient 2, whole exome sequencing analysis identified a 5,807-kb deletion within the Xp22.31-p22.33 region (chrX: 2700083–8507807) (<xref ref-type="fig" rid="F5">Figure 5B</xref>). The deletion contained 26 genes, including <italic>XG</italic>, <italic>GYG2</italic>, <italic>ARSD-AS1</italic>, <italic>ARSD</italic>, <italic>ARSE</italic>, <italic>ARSH</italic>, <italic>ARSF</italic>, <italic>LINC01546</italic>, <italic>MXRA5</italic>, <italic>PRKX</italic>, <italic>RKX-AS1</italic>, <italic>LOC389906</italic>, <italic>LOC101928201</italic>, <italic>NLGN4X</italic>, <italic>LOC105373156</italic>, <italic>MIR4770</italic>, <italic>VCX3A</italic>, <italic>PUDP</italic>, <italic>MIR4767</italic>, <italic>STS</italic>, <italic>VCX-A</italic>, <italic>PNPLA4</italic>, <italic>MIR651</italic>, <italic>VCX2</italic>, <italic>VCX3B</italic>, and <italic>ANOS1</italic>. His parents did not undergo a whole exome sequencing analysis.</p>
<p>Both of the chromosome deletions on Xp22.31 detected by whole exome sequencing were not listed in the chromosome polymorphism database, the dbVar database, or the Database of Chromosomal Imbalance and Phenotype in Humans using Ensembl Resources (DECIPHER<sup><xref ref-type="fn" rid="footnote2">2</xref></sup>).</p>
</sec>
<sec id="S3.SS6">
<title>Literature Review</title>
<p>We did a literature review on case reports of KS with XLI, and the genotype–phenotype association of 20 cases was analyzed (<xref ref-type="supplementary-material" rid="TS2">Supplementary Table S2</xref>). This analysis revealed that 7 of the 20 patients had an intellectual disability (<xref ref-type="bibr" rid="B28">Klink et al., 1994</xref>; <xref ref-type="bibr" rid="B39">Martul et al., 1995</xref>; <xref ref-type="bibr" rid="B63">Weissörtel et al., 1998</xref>; <xref ref-type="bibr" rid="B34">Macarov et al., 2007</xref>; <xref ref-type="bibr" rid="B43">Melichar et al., 2007</xref>; <xref ref-type="bibr" rid="B12">Cho et al., 2012</xref>; <xref ref-type="bibr" rid="B26">Khelifa et al., 2013</xref>). Three of these patients had an <italic>NLGN4X</italic> deletion, while three patients did not (<xref ref-type="bibr" rid="B39">Martul et al., 1995</xref>; <xref ref-type="bibr" rid="B63">Weissörtel et al., 1998</xref>; <xref ref-type="bibr" rid="B34">Macarov et al., 2007</xref>; <xref ref-type="bibr" rid="B43">Melichar et al., 2007</xref>; <xref ref-type="bibr" rid="B12">Cho et al., 2012</xref>; <xref ref-type="bibr" rid="B26">Khelifa et al., 2013</xref>), and one case was unclear (<xref ref-type="bibr" rid="B28">Klink et al., 1994</xref>). There were three other cases with an <italic>NLGN4X</italic> deletion that demonstrated normal mental development (<xref ref-type="bibr" rid="B47">Mochel et al., 2008</xref>; <xref ref-type="bibr" rid="B33">Liu et al., 2016</xref>; <xref ref-type="bibr" rid="B51">Nagai et al., 2017</xref>). Previous literature indicated that the relationship between <italic>NLGN4X</italic> mutations and intellectual disability could not be definitively established (<xref ref-type="bibr" rid="B26">Khelifa et al., 2013</xref>). A previous summary pointed out that, among the nine patients with <italic>XLI</italic> reported in the literature (<xref ref-type="bibr" rid="B26">Khelifa et al., 2013</xref>), five patients had different degrees of intellectual disability, only one of which had a deletion of <italic>NLGN4X.</italic> Another patient who had a deletion of <italic>NLGN4X</italic> demonstrated normal mental development (<xref ref-type="bibr" rid="B26">Khelifa et al., 2013</xref>). Renal agenesis occurred in 8 of the 20 patients, which may be caused by an <italic>ANOS1</italic> deletion (<xref ref-type="bibr" rid="B39">Martul et al., 1995</xref>; <xref ref-type="bibr" rid="B32">Krishnamurthy et al., 2007</xref>; <xref ref-type="bibr" rid="B34">Macarov et al., 2007</xref>; <xref ref-type="bibr" rid="B61">Trevisson et al., 2015</xref>; <xref ref-type="bibr" rid="B65">Xu et al., 2015</xref>; <xref ref-type="bibr" rid="B51">Nagai et al., 2017</xref>). Previous literature also noted that patients with KS harboring a deletion in Xp22.3 were more likely to exhibit renal agenesis (<xref ref-type="bibr" rid="B27">Kirk et al., 1994</xref>). Among 17 patients with either X-linked KS or X-linked KS and XLI, 6 patients had only one kidney (<xref ref-type="bibr" rid="B27">Kirk et al., 1994</xref>). Obesity occurred in 5 of the 20 patients (<xref ref-type="bibr" rid="B39">Martul et al., 1995</xref>; <xref ref-type="bibr" rid="B63">Weissörtel et al., 1998</xref>; <xref ref-type="bibr" rid="B12">Cho et al., 2012</xref>; <xref ref-type="bibr" rid="B26">Khelifa et al., 2013</xref>; <xref ref-type="bibr" rid="B5">Berges-Raso et al., 2017</xref>). Among four cases with deletion of <italic>PNPLA4</italic>, two patients were obese, and one had fatty liver and hyperlipidemia (<xref ref-type="bibr" rid="B12">Cho et al., 2012</xref>; <xref ref-type="bibr" rid="B26">Khelifa et al., 2013</xref>; <xref ref-type="bibr" rid="B33">Liu et al., 2016</xref>; <xref ref-type="bibr" rid="B51">Nagai et al., 2017</xref>). Among the 11 cases with short stature, two had deletions of SHOX while three had deletions of <italic>ARSE</italic> (<xref ref-type="bibr" rid="B42">Meindl et al., 1993</xref>; <xref ref-type="bibr" rid="B39">Martul et al., 1995</xref>; <xref ref-type="bibr" rid="B40">Maya-Núñez et al., 1998</xref>; <xref ref-type="bibr" rid="B63">Weissörtel et al., 1998</xref>; <xref ref-type="bibr" rid="B32">Krishnamurthy et al., 2007</xref>; <xref ref-type="bibr" rid="B43">Melichar et al., 2007</xref>; <xref ref-type="bibr" rid="B47">Mochel et al., 2008</xref>; <xref ref-type="bibr" rid="B12">Cho et al., 2012</xref>; <xref ref-type="bibr" rid="B33">Liu et al., 2016</xref>; <xref ref-type="bibr" rid="B51">Nagai et al., 2017</xref>). Three of the 20 patients presented with chondrodysplasia punctate, of whom 2 cases had deletions in <italic>ARSE</italic> and 1 case was unclear (<xref ref-type="bibr" rid="B42">Meindl et al., 1993</xref>; <xref ref-type="bibr" rid="B43">Melichar et al., 2007</xref>; <xref ref-type="bibr" rid="B12">Cho et al., 2012</xref>). Among the three cases with X-linked ocular albinism, two cases had a deletion of <italic>GPR143</italic> (<xref ref-type="bibr" rid="B43">Melichar et al., 2007</xref>; <xref ref-type="bibr" rid="B12">Cho et al., 2012</xref>), and one case was unclear. One out of the 20 cases showed strabismus, but only deletion of <italic>STS</italic> and <italic>ANOS1</italic> was detected (<xref ref-type="bibr" rid="B39">Martul et al., 1995</xref>).</p>
</sec>
</sec>
<sec id="S4">
<title>Discussion</title>
<p>Our study recruited two KS patients presenting with XLI, obesity, and strabismus. A novel 3,923 kb deletion within the Xp22.31 region containing 7 genes and a novel 5,807 kb deletion within the Xp22.31–Xp22.33 region containing 26 genes were identified. Cytogenetically visible deletions of the X chromosome from Xp22.2 to Xpter may lead to nullisomy of the deleted region and result in variable contiguous gene syndromes. To date, several apparently unrelated phenotypes have been found to associate with certain gene deletions within Xp22.3 regions, including <italic>SHOX</italic> in regard to short stature, <italic>ARSE</italic> in regard to chondrodysplasia punctata, <italic>STS</italic> in regard to XLI, <italic>ANOS1</italic> in regard to KS, <italic>GPR143</italic> in regard to ocular albinism type 1 (OA1), <italic>VCX-A</italic> in regard to intellectual disability, and <italic>NLGN4X</italic> in regard to intellectual disability in conjunction with autism (<xref ref-type="bibr" rid="B32">Krishnamurthy et al., 2007</xref>; <xref ref-type="bibr" rid="B34">Macarov et al., 2007</xref>; <xref ref-type="bibr" rid="B47">Mochel et al., 2008</xref>; <xref ref-type="bibr" rid="B12">Cho et al., 2012</xref>; Ben <xref ref-type="bibr" rid="B26">Khelifa et al., 2013</xref>; <xref ref-type="bibr" rid="B61">Trevisson et al., 2015</xref>; <xref ref-type="bibr" rid="B65">Xu et al., 2015</xref>; <xref ref-type="bibr" rid="B33">Liu et al., 2016</xref>; <xref ref-type="bibr" rid="B51">Nagai et al., 2017</xref>).</p>
<p>Both patients had phenotypes consistent with KS and XLI, which may be explained by the deletion of <italic>ANOS1</italic> and <italic>STS</italic>. <italic>ANOS1</italic> is the first gene found to be associated with KS and initially identified in X-linked KS (<xref ref-type="bibr" rid="B16">de Castro et al., 2014</xref>, <xref ref-type="bibr" rid="B17">2017</xref>). Approximately 5–7% of patients with KS had a causative <italic>ANOS1</italic> mutation. Mutations in <italic>ANOS1</italic> are typically either nonsense mutations, frame shift mutations, or large gene deletions (<xref ref-type="bibr" rid="B53">Senthilraja et al., 2019</xref>). <italic>ANOS1</italic> contains 14 exons and encodes the extracellular adhesion protein amosmin-1, which mediates adhesion and axonal migration of GnRH neurons (<xref ref-type="bibr" rid="B55">Soussi-Yanicostas et al., 2002</xref>; <xref ref-type="bibr" rid="B9">Bribián et al., 2006</xref>; <xref ref-type="bibr" rid="B24">Gianola et al., 2009</xref>; <xref ref-type="bibr" rid="B66">Yanicostas et al., 2009</xref>; <xref ref-type="bibr" rid="B16">de Castro et al., 2014</xref>, <xref ref-type="bibr" rid="B17">2017</xref>; <xref ref-type="bibr" rid="B22">García-González et al., 2016</xref>; <xref ref-type="bibr" rid="B48">Murcia-Belmonte et al., 2016</xref>; <xref ref-type="bibr" rid="B58">Stamou and Georgopoulos, 2018</xref>). Anosmin-1 is largely present in different structures of the central nervous system, including the cerebral cortex, olfactory bulb, and other components of the olfactory system, and when mutated in KS may lead to satellite symptoms including anosmia and HH (<xref ref-type="bibr" rid="B22">García-González et al., 2016</xref>; <xref ref-type="bibr" rid="B17">de Castro et al., 2017</xref>; <xref ref-type="bibr" rid="B58">Stamou and Georgopoulos, 2018</xref>). Anosmin-1 was shown to play essential roles in the patterning of mitral and tufted cell axon collaterals to the olfactory cortex (<xref ref-type="bibr" rid="B55">Soussi-Yanicostas et al., 2002</xref>) and also interacts with FGFR1 (alias, KAL-2), thereby impairing the migration of oligodendrocyte precursors and producing substantial morphological changes in the new subventricular zone (<xref ref-type="bibr" rid="B9">Bribián et al., 2006</xref>; <xref ref-type="bibr" rid="B21">García-González et al., 2010</xref>; <xref ref-type="bibr" rid="B19">Esteban et al., 2013</xref>; <xref ref-type="bibr" rid="B49">Murcia-Belmonte et al., 2014</xref>; <xref ref-type="bibr" rid="B22">García-González et al., 2016</xref>). New hypotheses have been described to explain both the main and satellite neurological symptoms of KS with regard to alterations in myelination caused by anosmin-1 (<xref ref-type="bibr" rid="B23">Garcia-Gonzalez et al., 2013</xref>). Although different putative interacting proteins and mechanisms have been deeply studied (FGFR1, heparan sulfates, syndecans, glypicans, uPA, fibronectin, laminin, integrin-beta), the current understanding of the mechanism of anosmin-1 in KS remains far from complete (<xref ref-type="bibr" rid="B55">Soussi-Yanicostas et al., 2002</xref>; <xref ref-type="bibr" rid="B18">Dodé et al., 2003</xref>; <xref ref-type="bibr" rid="B9">Bribián et al., 2006</xref>; <xref ref-type="bibr" rid="B24">Gianola et al., 2009</xref>; <xref ref-type="bibr" rid="B66">Yanicostas et al., 2009</xref>; <xref ref-type="bibr" rid="B21">García-González et al., 2010</xref>, <xref ref-type="bibr" rid="B22">2016</xref>; <xref ref-type="bibr" rid="B19">Esteban et al., 2013</xref>; <xref ref-type="bibr" rid="B23">Garcia-Gonzalez et al., 2013</xref>; <xref ref-type="bibr" rid="B49">Murcia-Belmonte et al., 2014</xref>; <xref ref-type="bibr" rid="B48">Murcia-Belmonte et al., 2016</xref>). The complete deletion of <italic>ANOS1</italic> is rare (<xref ref-type="bibr" rid="B25">Hamada et al., 2013</xref>). Compared with patients with a point mutation in <italic>ANOS1</italic>, patients with complete deletion of <italic>ANOS1</italic> may present with other symptoms, such as short stature, chondrodysplasia punctata, intellectual disability, and steroid sulfatase deficiency (<xref ref-type="bibr" rid="B25">Hamada et al., 2013</xref>). These symptoms may be caused by deletions in genes located close to <italic>ANOS1</italic>. <italic>STS</italic> is located near <italic>ANOS1</italic> and encodes a steroid sulfatase enzyme that catalyzes the conversion of steroid sulfate precursors to estrogens, and defects in this process can cause XLI (<xref ref-type="bibr" rid="B25">Hamada et al., 2013</xref>).</p>
<p>The deleted fragments detected in patients 1 and 2 had six genes in common, including <italic>NLGN4X</italic>, <italic>VCX-A</italic>, <italic>PUDP</italic>, and <italic>PNPLA4</italic>, in addition to <italic>STS</italic> and <italic>ANOS1</italic>. <italic>GPR143</italic> (<italic>OA1</italic> gene), only identified as deleted in patient 1, has been linked to X-linked ocular albinism (OA1; OMIM 300500) (9). Mutations in <italic>GPR143</italic> cause Nystagmus 6, which presents with conjugate, horizontal oscillations of the eyes. Other associated features may include mildly decreased visual acuity, strabismus, and astigmatism. We suspected the association of <italic>GPR143</italic> with strabismus in patient 1, but a family proband with strabismus revealed a 7.7-Mb deletion within Xp22.2–Xp22.3 that did not encompass <italic>GPR143.</italic> Mutation of <italic>NLGN4X</italic> is associated with intellectual disability (OMIM: 300495), X-linked Asperger syndrome type 2 (OMIM: 300497), and autism (<xref ref-type="bibr" rid="B15">Daoud et al., 2009</xref>; <xref ref-type="bibr" rid="B54">Shi et al., 2013</xref>). <italic>VCX-A</italic> and <italic>VCX-3A</italic> deficiency has been previously shown to be associated with intellectual disability (<xref ref-type="bibr" rid="B13">Chocholska et al., 2006</xref>). Although both patients had <italic>NLGN4X</italic> and <italic>VCX-A</italic> deletions, neither had speech defects, intellectual disability, autism, or social disorders. Previous observations also indicated that the deletion of <italic>NLGN4X</italic> may be associated with normal mental development (<xref ref-type="bibr" rid="B26">Khelifa et al., 2013</xref>; <xref ref-type="bibr" rid="B51">Nagai et al., 2017</xref>). <italic>VCX</italic>-A deletion is associated with XLI (<xref ref-type="bibr" rid="B62">Van Esch et al., 2005</xref>; <xref ref-type="bibr" rid="B14">Cuevas-Covarrubias and González-Huerta, 2008</xref>), poor sperm production, and sexual development abnormalities (<xref ref-type="bibr" rid="B69">Zou et al., 2003</xref>). <italic>PNPLA4</italic> encodes a patatin-like phospholipase with triacylglycerolase and transacylase activity, which may be related to maintaining the homeostasis of adipocyte triglycerides. <italic>PNPLA4</italic> deletion has been reported in patients with XLI (<xref ref-type="bibr" rid="B50">Murugesan et al., 2013</xref>). Therefore, the remarkable elevation of triglyceride levels in patient 1 and obesity in both patients may be associated with loss of <italic>PNPLA4</italic>.</p>
<p>In patient 2, a 5,807-kb deletion was identified including <italic>XG</italic>, <italic>GYG2</italic>, <italic>ARSD-AS1</italic>, <italic>ARSD</italic>, <italic>ARSE</italic>, <italic>ARSH</italic>, <italic>ARSF</italic>, <italic>LINC01546</italic>, <italic>MXRA5</italic>, <italic>PRKX</italic>, <italic>PRKX-AS1</italic>, <italic>LOC389906</italic>, <italic>LOC101928201</italic>, <italic>NLGN4X</italic>, <italic>LOC105373156</italic>, <italic>MIR4770</italic>, <italic>VCX3A</italic>, <italic>PUDP</italic>, <italic>MIR4767</italic>, <italic>STS</italic>, <italic>VCX-A</italic>, <italic>PNPLA4</italic>, <italic>MIR651</italic>, <italic>VCX2</italic>, <italic>VCX3B</italic>, and <italic>ANOS1</italic>. In 1986, <xref ref-type="bibr" rid="B3">Ballabio et al. (1986)</xref> reported that variations in the <italic>XG</italic> gene were associated with XLI. The <italic>GYG2</italic> gene has a homologous sequence located on the Y chromosome, indicating that there may be compensation for the function of this gene (<xref ref-type="bibr" rid="B68">Zhai et al., 2000</xref>). <italic>ARSD</italic>, <italic>ARSE</italic>, and <italic>ARSF</italic> are members of the sulfatase family, which help maintain a crucial component of the bone and cartilage matrix. Studies have confirmed that X-linked punctate cartilage dysplasia is associated with <italic>ARSE</italic> and <italic>ARSF</italic> mutations (<xref ref-type="bibr" rid="B20">Franco et al., 1995</xref>; <xref ref-type="bibr" rid="B10">Brunetti-Pierri et al., 2003</xref>). Loss of these genes may be related to short stature. <italic>ARSE</italic> is responsible for chondrodysplasia punctata, which presents with punctate cartilage dysplasia, dwarfism, maxillary hypoplasia, hearing impairment, point calcification of the epiphysis, and cataracts. <italic>ARSH</italic> is involved in the synthesis of hormones, regulation of signaling pathways, and macromolecular degradation (<xref ref-type="bibr" rid="B52">Sardiello et al., 2005</xref>). Patient 2 presented short stature at initial diagnosis but achieved an adult height (AH) consistent with his parents’ height at later follow-up appointments and did not show any punctate cartilage dysplasia. Both patients in this study achieved a greater AH than their parental target height, in accordance with previous findings that KS patients tend to have greater AH compared to the general population, independent of specific genetic causes (<xref ref-type="bibr" rid="B36">Maione et al., 2020</xref>). <italic>MXRA5</italic> encodes proteins associated with extracellular matrix remodeling (<xref ref-type="bibr" rid="B2">Balakrishnan et al., 2014</xref>). <italic>VCX3A</italic>, only expressed in male germ cells, may mediate sperm production, whose defect is associated with XLI and may be associated with intellectual disability (<xref ref-type="bibr" rid="B62">Van Esch et al., 2005</xref>; <xref ref-type="bibr" rid="B14">Cuevas-Covarrubias and González-Huerta, 2008</xref>; <xref ref-type="bibr" rid="B26">Khelifa et al., 2013</xref>). A summary was generated to indicate the gene function, phenotype, and related diseases (<xref ref-type="supplementary-material" rid="TS3">Supplementary Table S3</xref>).</p>
<p>Mutation in <italic>NSMF</italic> may cause KS in an autosomal dominant inheritance mode. However, we discovered a likely benign heterogeneous missense variant of <italic>NSMF</italic> (c.410A &gt; C, p.Q137P) in patient 1, which was derived from the father, who had experienced normal pubertal development. Therefore, we supposed that this variation did not contribute to the pathogenesis of KS in patient 1 (<xref ref-type="bibr" rid="B58">Stamou and Georgopoulos, 2018</xref>).</p>
<p>Both patients revealed bilateral dysplasia of the olfactory bulb, tract, and sulcus by MRI, which are the most common findings in KS patients. MRI findings have been shown to have great accuracy and strong consistency when combined with smell test in differentiating KS patients from nIHH patients (<xref ref-type="bibr" rid="B29">Koenigkam-Santos et al., 2010</xref>; <xref ref-type="bibr" rid="B30">Koenigkam-Santos et al., 2011</xref>). A recent study that further analyzed MRI differences found that patients with KS showed differences in white matter between patients with and without mirror movements (<xref ref-type="bibr" rid="B29">Koenigkam-Santos et al., 2010</xref>).</p>
<p>The use of comparative genomic hybridization (CGH) arrays has increased the identification of genomic rearrangements and is an essential tool for the detection of microchromosomal deletions. Whole exome sequencing is the most frequently used genome sequencing method used to identify mutations in coding regions and untranslated regions (UTRs) related to disease and population evolution. We chose to use whole exome sequencing in this study because previous literature has indicated the possibility of a genomic rearrangement involving the <italic>ANOS1</italic> gene and a point mutation of the <italic>STS</italic> gene leading to KS and XLI (<xref ref-type="bibr" rid="B61">Trevisson et al., 2015</xref>).</p>
<p>Both of our patients are male patients. The prevalence of KS in male individuals greatly outweighs that in female individuals. This may be because <italic>ANOS1</italic> partially escapes X inactivation (<xref ref-type="bibr" rid="B18">Dodé et al., 2003</xref>). Female patients may therefore carry the deletion but not show an accordant phenotype (<xref ref-type="bibr" rid="B13">Chocholska et al., 2006</xref>). The onset age of both our patients is 14 years old, which is consistent with the majority of previous case reports (<xref ref-type="bibr" rid="B32">Krishnamurthy et al., 2007</xref>; <xref ref-type="bibr" rid="B34">Macarov et al., 2007</xref>; <xref ref-type="bibr" rid="B47">Mochel et al., 2008</xref>; <xref ref-type="bibr" rid="B12">Cho et al., 2012</xref>; <xref ref-type="bibr" rid="B26">Khelifa et al., 2013</xref>; <xref ref-type="bibr" rid="B61">Trevisson et al., 2015</xref>; <xref ref-type="bibr" rid="B65">Xu et al., 2015</xref>; <xref ref-type="bibr" rid="B33">Liu et al., 2016</xref>; <xref ref-type="bibr" rid="B51">Nagai et al., 2017</xref>). KS often presents with delayed pubertal development, and patients tend to be identified by clinicians during the period of puberty.</p>
</sec>
<sec id="S5">
<title>Conclusion</title>
<p>We identified two patients presenting with KS, ichthyosis, obesity, and strabismus caused by novel microdeletions in the X chromosome. Loss of <italic>ANOS1</italic> and <italic>STS</italic> is known to cause KS and ichthyosis. Obesity may be associated with loss of the <italic>PNPLA4</italic> gene. Our research shows a novel microdeletion in the X chromosome that leads to Kallmann–ichthyosis phenotype and also discovered that the observed phenotypes of obesity and strabismus may be caused by other gene deletions in the region, which requires further studies to better understand the relationship of these deletions to KS and XLI. For clinical endocrinologists, symptoms of obesity, strabismus, and ichthyosis should be evaluated in patients with X-linked recessive KS, which may be caused by genes located close to <italic>ANOS1</italic>.</p>
</sec>
<sec id="S6" sec-type="data-availability">
<title>Data Availability Statement</title>
<p>We have uploaded data to NCBI SRA data base with accession numbers <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="SRR11745079">SRR11745079</ext-link> and <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="SRR11745080">SRR11745080</ext-link>.</p>
</sec>
<sec id="S7">
<title>Ethics Statement</title>
<p>The studies involving human participants were reviewed and approved by the Ethics Committee of PUMCH. Written informed consent to participate in this study was provided by the participants’ legal guardian/next of kin. Written informed consent was obtained from the individual(s), and minor(s)’ legal guardian/next of kin, for the publication of any potentially identifiable images or data included in this article.</p>
</sec>
<sec id="S8">
<title>Author Contributions</title>
<p>WM designed and carried out the study and wrote the manuscript. JM, XWu, MN, and XWa designed the study and revised the manuscript. JM, XWu, LD, YS, and XL provided patient and sample. JZ helped carry on the study and contact patient. ZL contacted patient. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="conf1">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This work was supported by the National Key Research and Development Program of China (2016YFC0905102 and 2016YFA0101003), CAMS Innovation Fund for Medical Sciences (CIFMS) (2016-I2M-1-002 and 2017-I2M-3-007), and the Project of National Natural Science Foundation of China (81771576 and 81971375), and Beijing Municipal Natural Science Foundation (7202151).</p>
</fn>
</fn-group>
<fn-group>
<fn id="footnote1">
<label>1</label>
<p>
<ext-link ext-link-type="uri" xlink:href="https://varsome.com/">https://varsome.com/</ext-link>
</p>
</fn>
<fn id="footnote2">
<label>2</label>
<p>
<ext-link ext-link-type="uri" xlink:href="http://www.sanger.ac.uk/PostGenomics/decipher/">http://www.sanger.ac.uk/PostGenomics/decipher/</ext-link>
</p>
</fn>
</fn-group>
<sec id="S10" sec-type="supplementary material">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fgene.2020.00596/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fgene.2020.00596/full#supplementary-material</ext-link></p>
<supplementary-material content-type="local-data" id="FS1">
<label>FIGURE S1</label>
<caption>
<p>Variation NSMF gene, inherited from his father. Figure <bold>(A)</bold> shows mutation in NSMF (c.410A &gt; C and p.Q137P) chr9: 140342022-140353786 in patient I. The mutation would cause Kallmann syndrome in an autosomal dominant heritage model. It was also detected in his father shown by <bold>(B)</bold> who experienced normal pubertal development. <bold>(C)</bold> shows that the mother doesn’t have the mutation.</p>
</caption>
<media xlink:href="Figure_1.jpg">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="TS1">
<label>TABLE S1</label>
<caption>
<p>Laboratory assessments of patient 1 and 2 β-HCG: β-chorionic gonadotropin; 17a-OHP:17a hydroxyl-progesterone; DHEAS: Dehydroepiandrosterone Sulfate; 24hUFC:24h urine free cortisol; IGF-1: insulin-like growth factors-1; FT3: Free Triiodogonine; FT4: Free Thyroxine; TSH: Thyrotropin; F: Serum-free cortisol; ACTH: Adrenocorticotropic hormone; FSH(60min) and LH(60min): gonadotropins levels after triptorelin stimulating test.</p>
</caption>
<media xlink:href="Table_1.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="TS2">
<label>TABLE S2</label>
<caption>
<p>Literature review of 10 cases of KSand XLI.</p>
</caption>
<media xlink:href="Table_2.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="TS3">
<label>TABLE S3</label>
<caption>
<p>The function, relevant disease and phenotype ofgenes on Xp 22.3. KS:Kallmann Syndrome; XLI:X-linked ichthyosis.</p>
</caption>
<media xlink:href="Table_3.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abreu</surname><given-names>A. P.</given-names></name><name><surname>Trarbach</surname><given-names>E. B.</given-names></name><name><surname>de Castro</surname><given-names>M.</given-names></name><name><surname>Frade Costa</surname><given-names>E. M.</given-names></name><name><surname>Versiani</surname><given-names>B.</given-names></name><name><surname>Matias Baptista</surname><given-names>M. T.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Loss-of-function mutations in the genes encoding prokineticin-2 or prokineticin receptor-2 cause autosomal recessive Kallmann syndrome.</article-title>
<source/><italic>J. Clin. Endocrinol. Metab.</italic>
<volume>93</volume>
<fpage>4113</fpage>–<lpage>4118</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2008-0958</pub-id>
<pub-id pub-id-type="pmid">18682503</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balakrishnan</surname><given-names>L.</given-names></name><name><surname>Nirujogi</surname><given-names>R. S.</given-names></name><name><surname>Ahmad</surname><given-names>S.</given-names></name><name><surname>Bhattacharjee</surname><given-names>M.</given-names></name><name><surname>Manda</surname><given-names>S. S.</given-names></name><name><surname>Renuse</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Proteomic analysis of human osteoarthritis synovial fluid.</article-title>
<source/><italic>Clin. Proteomics.</italic>
<volume>11</volume>:<issue>6</issue>. <pub-id pub-id-type="doi">10.1186/1559-0275-11-6</pub-id>
<pub-id pub-id-type="pmid">24533825</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ballabio</surname><given-names>A.</given-names></name><name><surname>Parenti</surname><given-names>G.</given-names></name><name><surname>Tippett</surname><given-names>P.</given-names></name><name><surname>Mondello</surname><given-names>C.</given-names></name><name><surname>Di Maio</surname><given-names>S.</given-names></name><name><surname>Tenore</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>1986</year>). <article-title>X-linked ichthyosis, due to steroid sulphatase deficiency, associated with Kallmann syndrome (hypogonadotropic hypogonadism and anosmia): linkage relationships with Xg and cloned DNA sequences from the distal short arm of the X chromosome.</article-title>
<source/><italic>Hum. Genet.</italic>
<volume>72</volume>
<fpage>237</fpage>–<lpage>240</lpage>. <pub-id pub-id-type="doi">10.1007/bf00291885</pub-id>
<pub-id pub-id-type="pmid">3007328</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barraud</surname><given-names>S.</given-names></name><name><surname>Delemer</surname><given-names>B.</given-names></name><name><surname>Poirsier-Violle</surname><given-names>C.</given-names></name><name><surname>Bouligand</surname><given-names>J.</given-names></name><name><surname>Mérol</surname><given-names>J.-C.</given-names></name><name><surname>Grange</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2020</year>). <article-title>Congenital hypogonadotropic hypogonadism with anosmia and Gorlin features caused by a PTCH1 mutation reveals a new candidate gene for Kallmann syndrome.</article-title>
<source/><italic>Neuroendocrinology.</italic>
<pub-id pub-id-type="doi">10.1159/000506640</pub-id>
<comment>[Epub ahead of print]</comment>. <pub-id pub-id-type="pmid">32074614</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berges-Raso</surname><given-names>I.</given-names></name><name><surname>Giménez-Palop</surname><given-names>O.</given-names></name><name><surname>Caixas</surname><given-names>A.</given-names></name><name><surname>Gabau</surname><given-names>E.</given-names></name><name><surname>Casamitjana</surname><given-names>L.</given-names></name><name><surname>Capel</surname><given-names>I.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Kallmann syndrome and ichthiosis: a case of contiguous gene deletion syndrome.</article-title>
<source/><italic>Endocrinol. Diabetes Metab. Case Rep.</italic>
<volume>2017</volume>:<issue>EDM170083</issue>. <pub-id pub-id-type="doi">10.1530/EDM-17-0083</pub-id>
<pub-id pub-id-type="pmid">30352392</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boehm</surname><given-names>U.</given-names></name><name><surname>Bouloux</surname><given-names>P.</given-names></name><name><surname>Dattani</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>European consensus statement on congenital hypogonadotorpic hypogonadism-pathogenesis, diagnosis and treatment.</article-title>
<source/><italic>Nat. Rev. Endocrinol.</italic>
<volume>11</volume>
<fpage>547</fpage>–<lpage>564</lpage>. <pub-id pub-id-type="doi">10.1038/nrendo.2015.112</pub-id>
<pub-id pub-id-type="pmid">26194704</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonomi</surname><given-names>M.</given-names></name><name><surname>Vezzoli</surname><given-names>V.</given-names></name><name><surname>Krausz</surname><given-names>C.</given-names></name><name><surname>Guizzardi</surname><given-names>F.</given-names></name><name><surname>Vezzani</surname><given-names>S.</given-names></name><name><surname>Simoni</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Characteristics of a nationwide cohort of patients presenting with isolated hypogonadotropic hypogonadism (IHH).</article-title>
<source/><italic>Eur. J. Endocrinol.</italic>
<volume>178</volume>
<fpage>23</fpage>–<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1530/EJE-17-0065</pub-id>
<pub-id pub-id-type="pmid">28882981</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouilly</surname><given-names>J.</given-names></name><name><surname>Messina</surname><given-names>A.</given-names></name><name><surname>Papadakis</surname><given-names>G.</given-names></name><name><surname>Cassatella</surname><given-names>D.</given-names></name><name><surname>Xu</surname><given-names>C.</given-names></name><name><surname>Acierno</surname><given-names>J. S.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>DCC/NTN1 complex mutations in patients with congenital hypogonadotropic hypogonadism impair GnRH neuron development.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>27</volume>
<fpage>359</fpage>–<lpage>372</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddx408</pub-id>
<pub-id pub-id-type="pmid">29202173</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bribián</surname><given-names>A.</given-names></name><name><surname>Barallobre</surname><given-names>M. J.</given-names></name><name><surname>Soussi-Yanicostas</surname><given-names>N.</given-names></name><name><surname>de Castro</surname><given-names>F.</given-names></name></person-group> (<year>2006</year>). <article-title>Anosmin-1 modulates the FGF-2-dependent migration of oligodendrocyte precursors in the developing optic nerve.</article-title>
<source/><italic>Mol. Cell Neurosci.</italic>
<volume>33</volume>
<fpage>2</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2006.05.009</pub-id>
<pub-id pub-id-type="pmid">16876430</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brunetti-Pierri</surname><given-names>N.</given-names></name><name><surname>Andreucci</surname><given-names>M. V.</given-names></name><name><surname>Tuzzi</surname><given-names>R.</given-names></name><name><surname>Vega</surname><given-names>G. R.</given-names></name><name><surname>Gray</surname><given-names>G.</given-names></name><name><surname>McKeown</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>X-linked recessive chondrodysplasia punctata: spectrum of arylsulfatase E gene mutations and expanded clinical variability.</article-title>
<source/><italic>Am. J. Med. Genet. A.</italic>
<volume>117</volume>
<fpage>164</fpage>–<lpage>168</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.10950</pub-id>
<pub-id pub-id-type="pmid">12567415</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canto</surname><given-names>P.</given-names></name><name><surname>Munguia</surname><given-names>P.</given-names></name><name><surname>Söderlund</surname><given-names>D.</given-names></name><name><surname>Castro</surname><given-names>J.</given-names></name><name><surname>Mendez</surname><given-names>J.</given-names></name></person-group> (<year>2009</year>). <article-title>Genetic analysis in patients with Kallmann syndrome: coexistence of mutations in prokineticin receptor 2 and KAL1.</article-title>
<source/><italic>J. Androl.</italic>
<volume>30</volume>
<fpage>41</fpage>–<lpage>45</lpage>. <pub-id pub-id-type="doi">10.2164/jandrol.108.005314</pub-id>
<pub-id pub-id-type="pmid">18723471</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>E.-H.</given-names></name><name><surname>Kim</surname><given-names>S.-Y.</given-names></name><name><surname>Kim</surname><given-names>J.-K.</given-names></name></person-group> (<year>2012</year>). <article-title>A case of 9.7 Mb terminal Xp deletion including OA1 locus associated with contiguous gene syndrome.</article-title>
<source/><italic>J. Korean Med. Sci.</italic>
<volume>27</volume>
<fpage>1273</fpage>–<lpage>1277</lpage>. <pub-id pub-id-type="doi">10.3346/jkms.2012.27.10.1273</pub-id>
<pub-id pub-id-type="pmid">23091330</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chocholska</surname><given-names>S.</given-names></name><name><surname>Rossier</surname><given-names>E.</given-names></name><name><surname>Barbi</surname><given-names>G.</given-names></name><name><surname>Kehrer-Sawatzki</surname><given-names>H.</given-names></name></person-group> (<year>2006</year>). <article-title>Molecular cytogenetic analysis of a familial interstitial deletion Xp22. 2-22.3 with a highly variable phenotype in female carriers.</article-title>
<source/><italic>Am. J. Med. Genet. A</italic>
<volume>140</volume>
<fpage>604</fpage>–<lpage>610</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.31145</pub-id>
<pub-id pub-id-type="pmid">16470742</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuevas-Covarrubias</surname><given-names>S.</given-names></name><name><surname>González-Huerta</surname><given-names>L.</given-names></name></person-group> (<year>2008</year>). <article-title>Analysis of the VCX3A, VCX2 and VCX3B genes shows that VCX3A gene deletion is not sufficient to result in mental retardation in X-linked ichthyosis.</article-title>
<source/><italic>Br. J. Dermatol.</italic>
<volume>158</volume>
<fpage>483</fpage>–<lpage>486</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2133.200708373.x</pub-id><pub-id pub-id-type="pmid">18076704</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daoud</surname><given-names>H.</given-names></name><name><surname>Bonnet-Brilhault</surname><given-names>F.</given-names></name><name><surname>Védrine</surname><given-names>S.</given-names></name><name><surname>Demattéi</surname><given-names>M. V.</given-names></name><name><surname>Vourc’h</surname><given-names>P.</given-names></name><name><surname>Bayou</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Autism and nonsyndromic mental retardation associated with a de novo mutation in the NLGN4X gene promoter causing an increased expression level.</article-title>
<source/><italic>Biol. Psychiatry.</italic>
<volume>66</volume>
<fpage>906</fpage>–<lpage>910</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2009.05.008</pub-id>
<pub-id pub-id-type="pmid">19545860</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Castro</surname><given-names>F.</given-names></name><name><surname>Esteban</surname><given-names>P. F.</given-names></name><name><surname>Bribián</surname><given-names>A.</given-names></name><name><surname>Murcia-Belmonte</surname><given-names>V.</given-names></name><name><surname>García-González</surname><given-names>D.</given-names></name><name><surname>Clemente</surname><given-names>D.</given-names></name></person-group> (<year>2014</year>). <article-title>The adhesion molecule anosmin-1 in neurology: kallmann syndrome and beyond.</article-title>
<source/><italic>Adv. Neurobiol.</italic>
<volume>8</volume>
<fpage>273</fpage>–<lpage>292</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4614-8090-7_12</pub-id>
<pub-id pub-id-type="pmid">25300141</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Castro</surname><given-names>F.</given-names></name><name><surname>Seal</surname><given-names>R.</given-names></name><name><surname>Maggi</surname><given-names>R.</given-names></name></person-group>
<collab>Group of Hgnc consultants for KAL1 nomenclature.</collab> (<year>2017</year>). <article-title>ANOS1: a unified nomenclature for Kallmann syndrome 1 gene (KAL1) and anosmin-1.</article-title>
<source/><italic>Brief. Funct. Genomics</italic>
<volume>16</volume>
<fpage>205</fpage>–<lpage>210</lpage>. <pub-id pub-id-type="doi">10.1093/bfgp/elw037</pub-id>
<pub-id pub-id-type="pmid">27899353</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dodé</surname><given-names>C.</given-names></name><name><surname>Levilliers</surname><given-names>J.</given-names></name><name><surname>Dupont</surname><given-names>J.-M.</given-names></name><name><surname>De Paepe</surname><given-names>A.</given-names></name><name><surname>Le Dû</surname><given-names>N.</given-names></name><name><surname>Soussi-Yanicostas</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>33</volume>
<fpage>463</fpage>–<lpage>465</lpage>. <pub-id pub-id-type="doi">10.1038/ng1122</pub-id>
<pub-id pub-id-type="pmid">12627230</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esteban</surname><given-names>P. F.</given-names></name><name><surname>Murcia-Belmonte</surname><given-names>V.</given-names></name><name><surname>García-González</surname><given-names>D.</given-names></name><name><surname>de Castro</surname><given-names>F.</given-names></name></person-group> (<year>2013</year>). <article-title>The cysteine-rich region and the whey acidic protein domain are essential for anosmin-1 biological functions.</article-title>
<source/><italic>J. Neurochem</italic>
<volume>124</volume>
<fpage>708</fpage>–<lpage>720</lpage>. <pub-id pub-id-type="doi">10.1111/jnc.12104</pub-id>
<pub-id pub-id-type="pmid">23189990</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franco</surname><given-names>B.</given-names></name><name><surname>Meroni</surname><given-names>G.</given-names></name><name><surname>Parenti</surname><given-names>G.</given-names></name><name><surname>Levilliers</surname><given-names>J.</given-names></name><name><surname>Bernard</surname><given-names>L.</given-names></name><name><surname>Gebbia</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>1995</year>). <article-title>A cluster of sulfatase genes on Xp22. 3: mutations in chondrodysplasia punctata (CDPX) and implications for warfarin embryopathy.</article-title>
<source/><italic>Cell</italic>
<volume>81</volume>
<fpage>15</fpage>–<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(95)90367-4</pub-id><pub-id pub-id-type="pmid">7720070</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>García-González</surname><given-names>D.</given-names></name><name><surname>Clemente</surname><given-names>D.</given-names></name><name><surname>Coelho</surname><given-names>M.</given-names></name><name><surname>Esteban</surname><given-names>P. F.</given-names></name><name><surname>Soussi-Yanicostas</surname><given-names>N.</given-names></name><name><surname>de Castro</surname><given-names>F.</given-names></name></person-group> (<year>2010</year>). <article-title>Dynamic roles of FGF-2 and Anosmin-1 in the migration of neuronal precursors from the subventricular zone during pre-and postnatal development.</article-title>
<source/><italic>Exp. Neurol.</italic>
<volume>222</volume>
<fpage>285</fpage>–<lpage>295</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2010.01.006</pub-id>
<pub-id pub-id-type="pmid">20083104</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>García-González</surname><given-names>D.</given-names></name><name><surname>Murcia-Belmonte</surname><given-names>V.</given-names></name><name><surname>Esteban</surname><given-names>P. F.</given-names></name><name><surname>Ortega</surname><given-names>F.</given-names></name><name><surname>Díaz</surname><given-names>D.</given-names></name><name><surname>Sánchez-Vera</surname><given-names>I.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Anosmin-1 over-expression increases adult neurogenesis in the subventricular zone and neuroblast migration to the olfactory bulb.</article-title>
<source/><italic>Brain Struct. Funct.</italic>
<volume>221</volume>
<fpage>239</fpage>–<lpage>260</lpage>. <pub-id pub-id-type="doi">10.1007/s00429-014-0904-8</pub-id>
<pub-id pub-id-type="pmid">25300351</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Gonzalez</surname><given-names>D.</given-names></name><name><surname>Murcia-Belmonte</surname><given-names>V.</given-names></name><name><surname>Clemente</surname><given-names>D.</given-names></name><name><surname>De Castro</surname><given-names>F.</given-names></name></person-group> (<year>2013</year>). <article-title>Olfactory system and demyelination.</article-title>
<source/><italic>Anat. Rec.</italic>
<volume>296</volume>
<fpage>1424</fpage>–<lpage>1434</lpage>. <pub-id pub-id-type="doi">10.1002/ar.22736</pub-id>
<pub-id pub-id-type="pmid">23904351</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gianola</surname><given-names>S.</given-names></name><name><surname>de Castro</surname><given-names>F.</given-names></name><name><surname>Rossi</surname><given-names>F.</given-names></name></person-group> (<year>2009</year>). <article-title>Anosmin-1 stimulates outgrowth and branching of developing Purkinje axons.</article-title>
<source/><italic>Neuroscience</italic>
<volume>158</volume>
<fpage>570</fpage>–<lpage>584</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2008.10.022</pub-id>
<pub-id pub-id-type="pmid">19013504</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamada</surname><given-names>A. J.</given-names></name><name><surname>Esteves</surname><given-names>S. C.</given-names></name><name><surname>Agarwal</surname><given-names>A.</given-names></name></person-group> (<year>2013</year>). <article-title>A comprehensive review of genetics and genetic testing in azoospermia.</article-title>
<source/><italic>Clinics.</italic>
<volume>68</volume>
<fpage>39</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.6061/clinics/2013(sup01)06</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khelifa</surname><given-names>H. B.</given-names></name><name><surname>Soyah</surname><given-names>N.</given-names></name><name><surname>Ben-Abdallah-Bouhjar</surname><given-names>I.</given-names></name><name><surname>Gritly</surname><given-names>R.</given-names></name><name><surname>Sanlaville</surname><given-names>D.</given-names></name><name><surname>Elghezal</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Xp22. 3 interstitial deletion: a recognizable chromosomal abnormality encompassing VCX3A and STS genes in a patient with X-linked ichthyosis and mental retardation.</article-title>
<source/><italic>Gene</italic>
<volume>527</volume>
<fpage>578</fpage>–<lpage>583</lpage>. <pub-id pub-id-type="doi">10.1016/j.gene.2013.06.018</pub-id>
<pub-id pub-id-type="pmid">23791652</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirk</surname><given-names>J.</given-names></name><name><surname>Grant</surname><given-names>D.</given-names></name><name><surname>Besser</surname><given-names>G.</given-names></name><name><surname>Shalet</surname><given-names>S.</given-names></name><name><surname>Quinton</surname><given-names>R.</given-names></name><name><surname>Smith</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>1994</year>). <article-title>Unilateral renal aplasia in X-linked Kallmann’s syndrome.</article-title>
<source/><italic>Clin. Genet.</italic>
<volume>46</volume>
<fpage>260</fpage>–<lpage>262</lpage>. <pub-id pub-id-type="doi">10.1111/j.1399-0004.1994.tb04238.x</pub-id>
<pub-id pub-id-type="pmid">7820942</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klink</surname><given-names>A.</given-names></name><name><surname>Meindl</surname><given-names>A.</given-names></name><name><surname>Hellebrand</surname><given-names>H.</given-names></name><name><surname>Rappold</surname><given-names>G. A.</given-names></name></person-group> (<year>1994</year>). <article-title>A patient with an interstitial deletion in Xp22. 3 locates the gene for X-linked recessive chondrodysplasia punctata to within a one megabase interval.</article-title>
<source/><italic>Hum. Genet.</italic>
<volume>93</volume>
<fpage>463</fpage>–<lpage>466</lpage>. <pub-id pub-id-type="doi">10.1007/bf00201677</pub-id>
<pub-id pub-id-type="pmid">8168818</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koenigkam-Santos</surname><given-names>M.</given-names></name><name><surname>de Castro</surname><given-names>M.</given-names></name><name><surname>Versiani</surname><given-names>B. R.</given-names></name><name><surname>Diniz</surname><given-names>P. R. B.</given-names></name><name><surname>Santos</surname><given-names>A. C.</given-names></name></person-group> (<year>2010</year>). <article-title>Kallmann syndrome and mirror movements: white matter quantitative evaluation with magnetic resonance imaging.</article-title>
<source/><italic>J. Neurol. Sci.</italic>
<volume>292</volume>
<fpage>40</fpage>–<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2010.02.010</pub-id>
<pub-id pub-id-type="pmid">20211475</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koenigkam-Santos</surname><given-names>M.</given-names></name><name><surname>Santos</surname><given-names>A. C.</given-names></name><name><surname>Versiani</surname><given-names>B. R.</given-names></name><name><surname>Diniz</surname><given-names>P. R. B.</given-names></name><name><surname>Junior</surname><given-names>J. E.</given-names></name><name><surname>De Castro</surname><given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>Quantitative magnetic resonance imaging evaluation of the olfactory system in Kallmann syndrome: correlation with a clinical smell test.</article-title>
<source/><italic>Neuroendocrinology</italic>
<volume>94</volume>
<fpage>209</fpage>–<lpage>217</lpage>. <pub-id pub-id-type="doi">10.1159/000328437</pub-id>
<pub-id pub-id-type="pmid">21606642</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Köhn</surname><given-names>F.</given-names></name><name><surname>Schuppe</surname><given-names>H.</given-names></name></person-group> (<year>2014</year>). <article-title>Male infertility–pathogenic factors.</article-title>
<source/><italic>MMW Fortschr. Med.</italic>
<volume>156</volume>
<fpage>40</fpage>–<lpage>43</lpage>.</mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnamurthy</surname><given-names>S.</given-names></name><name><surname>Kapoor</surname><given-names>S.</given-names></name><name><surname>Yadav</surname><given-names>S.</given-names></name></person-group> (<year>2007</year>). <article-title>Nephrotic syndrome with X-linked ichthyosis, Kallmann Syndrome and unilateral renal agenesis.</article-title>
<source/><italic>Indian Pediatr.</italic>
<volume>44</volume>
<fpage>301</fpage>–<lpage>303</lpage>.<pub-id pub-id-type="pmid">17468528</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Bai</surname><given-names>N.</given-names></name><name><surname>Kong</surname><given-names>X.</given-names></name></person-group> (<year>2016</year>). <article-title>Genetic analysis of a rare case with Kallman syndrome and steroid sulfatase deficiency.</article-title>
<source/><italic>Zhonghua Yi Xue Yi Chuan Xue Za Zhi.</italic>
<volume>33</volume>
<fpage>349</fpage>–<lpage>352</lpage>. <pub-id pub-id-type="doi">10.3760/cma.j.issn.1003-9406.2016.03.016</pub-id>
<pub-id pub-id-type="pmid">27264819</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macarov</surname><given-names>M.</given-names></name><name><surname>Zeigler</surname><given-names>M.</given-names></name><name><surname>Newman</surname><given-names>J.</given-names></name><name><surname>Strich</surname><given-names>D.</given-names></name><name><surname>Sury</surname><given-names>V.</given-names></name><name><surname>Tennenbaum</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Deletions of VCX-A and NLGN4: a variable phenotype including normal intellect.</article-title>
<source/><italic>J. Intellect. Disabil. Res.</italic>
<volume>51</volume>
<fpage>329</fpage>–<lpage>333</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2788.2006.00880.x</pub-id>
<pub-id pub-id-type="pmid">17391250</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maione</surname><given-names>L.</given-names></name><name><surname>Dwyer</surname><given-names>A. A.</given-names></name><name><surname>Francou</surname><given-names>B.</given-names></name><name><surname>Guiochon-Mantel</surname><given-names>A.</given-names></name><name><surname>Binart</surname><given-names>N.</given-names></name><name><surname>Bouligand</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Genetic counseling for congenital hypogonadotropic hypogonadism and Kallmann syndrome: new challenges in the era of oligogenism and next generation sequencing.</article-title>
<source/><italic>Eur. J. Endocrinol.</italic>
<volume>178</volume>
<fpage>R55</fpage>–<lpage>R80</lpage>. <pub-id pub-id-type="doi">10.1530/EJE-17-0749</pub-id>
<pub-id pub-id-type="pmid">29330225</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maione</surname><given-names>L.</given-names></name><name><surname>Pala</surname><given-names>G.</given-names></name><name><surname>Bouvattier</surname><given-names>C.</given-names></name><name><surname>Trabado</surname><given-names>S.</given-names></name><name><surname>Papadakis</surname><given-names>G.</given-names></name><name><surname>Chanson</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2020</year>). <article-title>Congenital hypogonadotropic hypogonadism/Kallmann Syndrome is associated with statural gain in both men and women: a monocentric study.</article-title>
<source/><italic>Eur. J. Endocrinol.</italic>
<volume>182</volume>:<issue>185</issue>. <pub-id pub-id-type="doi">10.1530/EJE-19-0537</pub-id>
<pub-id pub-id-type="pmid">31770102</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malone</surname><given-names>S. A.</given-names></name><name><surname>Papadakis</surname><given-names>G. E.</given-names></name><name><surname>Messina</surname><given-names>A.</given-names></name><name><surname>Mimouni</surname><given-names>N. E. H.</given-names></name><name><surname>Trova</surname><given-names>S.</given-names></name><name><surname>Imbernon</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Defective AMH signaling disrupts GnRH neuron development and function and contributes to hypogonadotropic hypogonadism.</article-title>
<source/><italic>eLife</italic>
<volume>8</volume>:<issue>e47198</issue>. <pub-id pub-id-type="doi">10.7554/eLife.47198</pub-id>
<pub-id pub-id-type="pmid">31291191</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marcos</surname><given-names>S.</given-names></name><name><surname>Monnier</surname><given-names>C.</given-names></name><name><surname>Rovira</surname><given-names>X.</given-names></name><name><surname>Fouveaut</surname><given-names>C.</given-names></name><name><surname>Pitteloud</surname><given-names>N.</given-names></name><name><surname>Ango</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Defective signaling through plexin-A1 compromises the development of the peripheral olfactory system and neuroendocrine reproductive axis in mice.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>26</volume>
<fpage>2006</fpage>–<lpage>2017</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddx080</pub-id>
<pub-id pub-id-type="pmid">28334861</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martul</surname><given-names>P.</given-names></name><name><surname>Plneda</surname><given-names>J.</given-names></name><name><surname>Levllllers</surname><given-names>J.</given-names></name><name><surname>Vszquez</surname><given-names>J.</given-names></name><name><surname>Rodriguez-Soriano</surname><given-names>J.</given-names></name><name><surname>Loridan</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>1995</year>). <article-title>Hypogonadotrophic hypogonadism with hyposmia, X-linked ichthyosis, and renal malformation syndrome.</article-title>
<source/><italic>Clin. Endocrinol.</italic>
<volume>42</volume>
<fpage>121</fpage>–<lpage>128</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2265.1995.tb01851.x</pub-id>
<pub-id pub-id-type="pmid">7704955</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maya-Núñez</surname><given-names>G.</given-names></name><name><surname>Cuevas-Covarrubias</surname><given-names>S.</given-names></name><name><surname>Carlos Zenteno</surname><given-names>J.</given-names></name><name><surname>Ulloa-Aguirre</surname><given-names>A.</given-names></name><name><surname>Kofman-Alfaro</surname><given-names>S.</given-names></name><name><surname>Pablo Méndez</surname><given-names>J.</given-names></name></person-group> (<year>1998</year>). <article-title>Contiguous gene syndrome due to deletion of the first three exons of the Kallmann gene and complete deletion of the steroid sulphatase gene.</article-title>
<source/><italic>Clin. Endocrinol.</italic>
<volume>148</volume>
<fpage>713</fpage>–<lpage>718</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2265.1998.00406.x</pub-id>
<pub-id pub-id-type="pmid">9713559</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maya-Nuñez</surname><given-names>G.</given-names></name><name><surname>Torres</surname><given-names>L.</given-names></name><name><surname>Ulloa-Aguirre</surname><given-names>A.</given-names></name><name><surname>Carlos Zenteno</surname><given-names>J.</given-names></name><name><surname>Cuevas-Covarrubias</surname><given-names>S.</given-names></name><name><surname>Saavedra-Ontiveros</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>1999</year>). <article-title>An atypical contiguous gene syndrome: molecular studies in a family with X-linked Kallmann’s syndrome and X-linked ichthyosis.</article-title>
<source/><italic>Clin. Endocrinol.</italic>
<volume>50</volume>
<fpage>157</fpage>–<lpage>162</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2265.1999.00588.x</pub-id>
<pub-id pub-id-type="pmid">10396356</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meindl</surname><given-names>A.</given-names></name><name><surname>Hosenfeld</surname><given-names>D.</given-names></name><name><surname>Brückl</surname><given-names>W.</given-names></name><name><surname>Schuffenhauer</surname><given-names>S.</given-names></name><name><surname>Jenderny</surname><given-names>J.</given-names></name><name><surname>Bacskulin</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>1993</year>). <article-title>Analysis of a terminal Xp22. 3 deletion in a patient with six monogenic disorders: implications for the mapping of X linked ocular albinism.</article-title>
<source/><italic>J. Med. Genet.</italic>
<volume>30</volume>
<fpage>838</fpage>–<lpage>842</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.30.10.838</pub-id>
<pub-id pub-id-type="pmid">8230160</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melichar</surname><given-names>V. O.</given-names></name><name><surname>Guth</surname><given-names>S.</given-names></name><name><surname>Hellebrand</surname><given-names>H.</given-names></name><name><surname>Meindl</surname><given-names>A.</given-names></name><name><surname>Hardt</surname><given-names>K. V. D.</given-names></name><name><surname>Kraus</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>A male infant with a 9.6 Mb terminal Xp deletion including the OA1 locus: limit of viability of Xp deletions in males.</article-title>
<source/><italic>Am. J. Med. Genet. A</italic>
<volume>143</volume>
<fpage>135</fpage>–<lpage>141</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.31451</pub-id>
<pub-id pub-id-type="pmid">17163525</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Messina</surname><given-names>A.</given-names></name><name><surname>Pulli</surname><given-names>K.</given-names></name><name><surname>Santini</surname><given-names>S.</given-names></name><name><surname>Acierno</surname><given-names>J.</given-names></name><name><surname>Känsäkoski</surname><given-names>J.</given-names></name><name><surname>Cassatella</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2020</year>). <article-title>Neuron-derived neurotrophic factor is mutated in congenital hypogonadotropic hypogonadism.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>106</volume>
<fpage>58</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2019.12.003</pub-id>
<pub-id pub-id-type="pmid">31883645</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miraoui</surname><given-names>H.</given-names></name><name><surname>Dwyer</surname><given-names>A. A.</given-names></name><name><surname>Sykiotis</surname><given-names>G. P.</given-names></name><name><surname>Plummer</surname><given-names>L.</given-names></name><name><surname>Chung</surname><given-names>W.</given-names></name><name><surname>Feng</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Mutations in FGF17, IL17RD, DUSP6, SPRY4, and FLRT3 are identified in individuals with congenital hypogonadotropic hypogonadism.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>92</volume>
<fpage>725</fpage>–<lpage>743</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2013.04.008</pub-id>
<pub-id pub-id-type="pmid">23643382</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>A. L.</given-names></name><name><surname>Dwyer</surname><given-names>A.</given-names></name><name><surname>Pitteloud</surname><given-names>N.</given-names></name><name><surname>Quinton</surname><given-names>R.</given-names></name></person-group> (<year>2011</year>). <article-title>Genetic basis and variable phenotypic expression of Kallmann syndrome: towards a unifying theory.</article-title>
<source/><italic>Trends Endocrinol. Metab.</italic>
<volume>22</volume>
<fpage>249</fpage>–<lpage>258</lpage>. <pub-id pub-id-type="doi">10.1016/j.tem.2011.03.002</pub-id>
<pub-id pub-id-type="pmid">21511493</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mochel</surname><given-names>F.</given-names></name><name><surname>Missirian</surname><given-names>C.</given-names></name><name><surname>Reynaud</surname><given-names>R.</given-names></name><name><surname>Moncla</surname><given-names>A.</given-names></name></person-group> (<year>2008</year>). <article-title>Normal intelligence and social interactions in a male patient despite the deletion of NLGN4X and the VCX genes.</article-title>
<source/><italic>Eur. J. Med. Genet.</italic>
<volume>51</volume>
<fpage>68</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmg.2007.11.002</pub-id>
<pub-id pub-id-type="pmid">18194880</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murcia-Belmonte</surname><given-names>V.</given-names></name><name><surname>Esteban</surname><given-names>P. F.</given-names></name><name><surname>Martínez-Hernández</surname><given-names>J.</given-names></name><name><surname>Gruart</surname><given-names>A.</given-names></name><name><surname>Luján</surname><given-names>R.</given-names></name><name><surname>Delgado-García</surname><given-names>J. M.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Anosmin-1 over-expression regulates oligodendrocyte precursor cell proliferation, migration and myelin sheath thickness.</article-title>
<source/><italic>Brain Struct. Funct.</italic>
<volume>221</volume>
<fpage>1365</fpage>–<lpage>1385</lpage>. <pub-id pub-id-type="doi">10.1007/s00429-014-0977-4</pub-id>
<pub-id pub-id-type="pmid">25662897</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murcia-Belmonte</surname><given-names>V.</given-names></name><name><surname>Medina-Rodríguez</surname><given-names>E. M.</given-names></name><name><surname>Bribián</surname><given-names>A.</given-names></name><name><surname>de Castro</surname><given-names>F.</given-names></name><name><surname>Esteban</surname><given-names>P. F.</given-names></name></person-group> (<year>2014</year>). <article-title>ERK1/2 signaling is essential for the chemoattraction exerted by human FGF2 and human anosmin-1 on newborn rat and mouse OPCs via FGFR1.</article-title>
<source/><italic>Glia</italic>
<volume>62</volume>
<fpage>374</fpage>–<lpage>386</lpage>. <pub-id pub-id-type="doi">10.1002/glia.22609</pub-id>
<pub-id pub-id-type="pmid">24375670</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murugesan</surname><given-names>S.</given-names></name><name><surname>Goldberg</surname><given-names>E. B.</given-names></name><name><surname>Dou</surname><given-names>E.</given-names></name><name><surname>Brown</surname><given-names>W. J.</given-names></name></person-group> (<year>2013</year>). <article-title>Identification of diverse lipid droplet targeting motifs in the PNPLA family of triglyceride lipases.</article-title>
<source/><italic>PLoS One</italic>
<volume>8</volume>:<issue>e64950</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0064950</pub-id>
<pub-id pub-id-type="pmid">23741432</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagai</surname><given-names>K.</given-names></name><name><surname>Shima</surname><given-names>H.</given-names></name><name><surname>Kamimura</surname><given-names>M.</given-names></name><name><surname>Kanno</surname><given-names>J.</given-names></name><name><surname>Suzuki</surname><given-names>E.</given-names></name><name><surname>Ishiguro</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Xp22. 31 microdeletion due to microhomology-mediated break-induced replication in a boy with contiguous gene deletion syndrome.</article-title>
<source/><italic>Cytogenet. Genome Res.</italic>
<volume>151</volume>
<fpage>1</fpage>–<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1159/000458469</pub-id>
<pub-id pub-id-type="pmid">28253503</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sardiello</surname><given-names>M.</given-names></name><name><surname>Annunziata</surname><given-names>I.</given-names></name><name><surname>Roma</surname><given-names>G.</given-names></name><name><surname>Ballabio</surname><given-names>A.</given-names></name></person-group> (<year>2005</year>). <article-title>Sulfatases and sulfatase modifying factors: an exclusive and promiscuous relationship.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>14</volume>
<fpage>3203</fpage>–<lpage>3217</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddi351</pub-id>
<pub-id pub-id-type="pmid">16174644</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Senthilraja</surname><given-names>M.</given-names></name><name><surname>Chapla</surname><given-names>A.</given-names></name><name><surname>Jebasingh</surname><given-names>F. K.</given-names></name><name><surname>Naik</surname><given-names>D.</given-names></name><name><surname>Paul</surname><given-names>T. V.</given-names></name><name><surname>Thomas</surname><given-names>N.</given-names></name></person-group> (<year>2019</year>). <article-title>Parallel Multi-Gene panel testing for diagnosis of idiopathic hypogonadotropic hypogonadism/Kallmann Syndrome.</article-title>
<source/><italic>Case Rep. Genet.</italic>
<volume>2019</volume>:<issue>218514</issue>. <pub-id pub-id-type="doi">10.1155/2019/4218514</pub-id>
<pub-id pub-id-type="pmid">31781422</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>L.</given-names></name><name><surname>Chang</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>P.</given-names></name><name><surname>Coba</surname><given-names>M. P.</given-names></name><name><surname>Lu</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>K.</given-names></name></person-group> (<year>2013</year>). <article-title>The functional genetic link of NLGN4X knockdown and neurodevelopment in neural stem cells.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>22</volume>
<fpage>3749</fpage>–<lpage>3760</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddt226</pub-id>
<pub-id pub-id-type="pmid">23710042</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soussi-Yanicostas</surname><given-names>N.</given-names></name><name><surname>de Castro</surname><given-names>F.</given-names></name><name><surname>Julliard</surname><given-names>A. K.</given-names></name><name><surname>Perfettini</surname><given-names>I.</given-names></name><name><surname>Chédotal</surname><given-names>A.</given-names></name><name><surname>Petit</surname><given-names>C.</given-names></name></person-group> (<year>2002</year>). <article-title>Anosmin-1, defective in the X-linked form of Kallmann syndrome, promotes axonal branch formation from olfactory bulb output neurons.</article-title>
<source/><italic>Cell</italic>
<volume>109</volume>
<fpage>217</fpage>–<lpage>228</lpage>. <pub-id pub-id-type="doi">10.1016/s0092-8674(02)00713-4</pub-id><pub-id pub-id-type="pmid">12007408</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stamou</surname><given-names>M.</given-names></name><name><surname>Cox</surname><given-names>K.</given-names></name><name><surname>Crowley</surname><given-names>W. F.</given-names><suffix>Jr.</suffix></name></person-group> (<year>2016</year>). <article-title>Discovering genes essential to the hypothalamic regulation of human reproduction using a human disease model: adjusting to life in the “-Omics” era.</article-title>
<source/><italic>Endocr. Rev.</italic>
<volume>2016</volume>
<fpage>4</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1210/er.2015-1045.2016.1.test</pub-id>
<pub-id pub-id-type="pmid">27454361</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stamou</surname><given-names>M.</given-names></name><name><surname>Ng</surname><given-names>S.-Y.</given-names></name><name><surname>Brand</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Plummer</surname><given-names>L.</given-names></name><name><surname>Best</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2020</year>). <article-title>A balanced translocation in Kallmann Syndrome implicates a long noncoding RNA, RMST, as a GnRH neuronal regulator.</article-title>
<source/><italic>J. Clin. Endocrinol. Metab.</italic>
<volume>105</volume>:<issue>dgz011</issue>. <pub-id pub-id-type="doi">10.1210/clinem/dgz011</pub-id>
<pub-id pub-id-type="pmid">31628846</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stamou</surname><given-names>M. I.</given-names></name><name><surname>Georgopoulos</surname><given-names>N. A.</given-names></name></person-group> (<year>2018</year>). <article-title>Kallmann syndrome: phenotype and genotype of hypogonadotropic hypogonadism.</article-title>
<source/><italic>Metabolism</italic>
<volume>86</volume>
<fpage>124</fpage>–<lpage>134</lpage>. <pub-id pub-id-type="doi">10.1016/j.metabol.2017.10.012</pub-id>
<pub-id pub-id-type="pmid">29108899</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeichi</surname><given-names>T.</given-names></name><name><surname>Akiyama</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Inherited ichthyosis: non-syndromic forms.</article-title>
<source/><italic>J. Dermatol.</italic>
<volume>43</volume>
<fpage>242</fpage>–<lpage>251</lpage>. <pub-id pub-id-type="doi">10.1111/1346-8138.13243</pub-id>
<pub-id pub-id-type="pmid">26945532</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trarbach</surname><given-names>E. B.</given-names></name><name><surname>Baptista</surname><given-names>M. T.</given-names></name><name><surname>Garmes</surname><given-names>H. M.</given-names></name><name><surname>Hackel</surname><given-names>C.</given-names></name></person-group> (<year>2005</year>). <article-title>Molecular analysis of KAL-1, GnRH-R, NELF and EBF2 genes in a series of Kallmann syndrome and normosmic hypogonadotropic hypogonadism patients.</article-title>
<source/><italic>J. Endocrinol.</italic>
<volume>187</volume>
<fpage>361</fpage>–<lpage>368</lpage>. <pub-id pub-id-type="doi">10.1677/joe.1.06103</pub-id>
<pub-id pub-id-type="pmid">16423815</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trevisson</surname><given-names>E.</given-names></name><name><surname>Ludwig</surname><given-names>K.</given-names></name><name><surname>Casarin</surname><given-names>A.</given-names></name><name><surname>Di Meglio</surname><given-names>A.</given-names></name><name><surname>Greggio</surname><given-names>N. A.</given-names></name><name><surname>Manara</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Ichthyosis and Kallmann syndrome: not always a contiguous gene syndrome.</article-title>
<source/><italic>J. Dermatol Sci.</italic>
<volume>78</volume>
<fpage>158</fpage>–<lpage>160</lpage>. <pub-id pub-id-type="doi">10.1016/j.jdermsci.2015.02.005</pub-id>
<pub-id pub-id-type="pmid">25726327</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Esch</surname><given-names>H.</given-names></name><name><surname>Hollanders</surname><given-names>K.</given-names></name><name><surname>Badisco</surname><given-names>L.</given-names></name><name><surname>Melotte</surname><given-names>C.</given-names></name><name><surname>Van Hummelen</surname><given-names>P.</given-names></name><name><surname>Vermeesch</surname><given-names>J. R.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Deletion of VCX-A due to NAHR plays a major role in the occurrence of mental retardation in patients with X-linked ichthyosis.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>14</volume>
<fpage>1795</fpage>–<lpage>1803</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddi186</pub-id>
<pub-id pub-id-type="pmid">15888481</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weissörtel</surname><given-names>R.</given-names></name><name><surname>Strom</surname><given-names>T.</given-names></name><name><surname>Dörr</surname><given-names>H.</given-names></name><name><surname>Rauch</surname><given-names>A.</given-names></name><name><surname>Meitinger</surname><given-names>T.</given-names></name></person-group> (<year>1998</year>). <article-title>Analysis of an interstitial deletion in a patient with Kallmann syndrome, X-linked ichthyosis and mental retardation.</article-title>
<source/><italic>Clin. Genet.</italic>
<volume>54</volume>
<fpage>45</fpage>–<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1111/j.1399-0004.1998.tb03692.x</pub-id>
<pub-id pub-id-type="pmid">9727739</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>C.</given-names></name><name><surname>Messina</surname><given-names>A.</given-names></name><name><surname>Somm</surname><given-names>E.</given-names></name><name><surname>Miraoui</surname><given-names>H.</given-names></name><name><surname>Kinnunen</surname><given-names>T.</given-names></name><name><surname>Acierno</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>KLB, encoding β-Klotho, is mutated in patients with congenital hypogonadotropic hypogonadism.</article-title>
<source/><italic>EMBO Mol. Med.</italic>
<volume>9</volume>
<fpage>1379</fpage>–<lpage>1397</lpage>. <pub-id pub-id-type="doi">10.15252/emmm.201607376</pub-id>
<pub-id pub-id-type="pmid">28754744</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>T.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name></person-group> (<year>2015</year>). <article-title>Novel homozygous deletion of segmental KAL1 and entire STS cause Kallmann syndrome and X-linked ichthyosis in a Chinese family.</article-title>
<source/><italic>Andrologia</italic>
<volume>47</volume>
<fpage>1160</fpage>–<lpage>1165</lpage>. <pub-id pub-id-type="doi">10.1111/and.12397</pub-id>
<pub-id pub-id-type="pmid">25597551</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yanicostas</surname><given-names>C.</given-names></name><name><surname>Herbomel</surname><given-names>E.</given-names></name><name><surname>Dipietromaria</surname><given-names>A.</given-names></name><name><surname>Soussi-Yanicostas</surname><given-names>N.</given-names></name></person-group> (<year>2009</year>). <article-title>Anosmin-1a is required for fasciculation and terminal targeting of olfactory sensory neuron axons in the zebrafish olfactory system.</article-title>
<source/><italic>Mol. Cell Endocrinol.</italic>
<volume>312</volume>
<fpage>53</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2009.04.017</pub-id>
<pub-id pub-id-type="pmid">19464344</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>J.</given-names></name><name><surname>Xu</surname><given-names>C.</given-names></name><name><surname>Papadakis</surname><given-names>G. E.</given-names></name><name><surname>Acierno</surname><given-names>J. S.</given-names></name><name><surname>Maione</surname><given-names>L.</given-names></name><name><surname>Hietamäki</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Clinical management of congenital hypogonadotropic hypogonadism.</article-title>
<source/><italic>Endocr. Rev.</italic>
<volume>40</volume>
<fpage>669</fpage>–<lpage>710</lpage>. <pub-id pub-id-type="doi">10.1210/er.2018-00116</pub-id>
<pub-id pub-id-type="pmid">30698671</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhai</surname><given-names>L.</given-names></name><name><surname>Mu</surname><given-names>J.</given-names></name><name><surname>Zong</surname><given-names>H.</given-names></name><name><surname>DePaoli-Roach</surname><given-names>A. A.</given-names></name><name><surname>Roach</surname><given-names>P. J.</given-names></name></person-group> (<year>2000</year>). <article-title>Structure and chromosomal localization of the human glycogenin-2 gene GYG2.</article-title>
<source/><italic>Gene</italic>
<volume>242</volume>
<fpage>229</fpage>–<lpage>235</lpage>. <pub-id pub-id-type="doi">10.1016/s0378-1119(99)00520-x</pub-id><pub-id pub-id-type="pmid">10721716</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zou</surname><given-names>S. W.</given-names></name><name><surname>Zhang</surname><given-names>J. C.</given-names></name><name><surname>Zhang</surname><given-names>X. D.</given-names></name><name><surname>Miao</surname><given-names>S. Y.</given-names></name><name><surname>Zong</surname><given-names>S. D.</given-names></name><name><surname>Sheng</surname><given-names>Q.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Expression and localization of VCX/Y proteins and their possible involvement in regulation of ribosome assembly during spermatogenesis.</article-title>
<source/><italic>Cell Res.</italic>
<volume>13</volume>
<fpage>171</fpage>–<lpage>177</lpage>. <pub-id pub-id-type="doi">10.1038/sj.cr.7290161</pub-id>
<pub-id pub-id-type="pmid">12862317</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>